Latest / Stock Movers / Brunello Cucinelli Up, Siemens Rises, Novo Nordisk Soars
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move today in Europe. I'm Stephen Carroll and I'm
- 0:20Speaker 3: joined by Bloomberg reporter Chloe Melee coloed. Good morning. Let's
- 0:23Speaker 3: start off with Brunello Kuchinelli. A slew of news there, earnings,
- 0:27Speaker 3: but more as well. What can you tell us?
- 0:29Speaker 1: Yeah, so Brnello Cucinelli reported a jump in cells this morning,
- 0:33Speaker 1: and it also reaffirmed its targets for the year of
- 0:36Speaker 1: ten percent revenue growth. But perhaps more importantly than the
- 0:39Speaker 1: juicier part of the news today is that it did
- 0:41Speaker 1: push back against claims from a short seller. So short
- 0:44Speaker 1: seller Morpheus Research alleged a few days ago that Kuchinelli
- 0:48Speaker 1: continues to operate stores in Russia despite sanctions of course
- 0:51Speaker 1: inposts on the country, and even though the company said
- 0:54Speaker 1: that it had closed them, and that led to this
- 0:56Speaker 1: massive dip in the shares that's now recovered a little bit.
- 1:00Speaker 1: Brinelucationally said that all of its flagship stores in Russia
- 1:03Speaker 1: have always remained closed after the sanctions were introduced, and
- 1:07Speaker 1: the CEO. The co CEO said, the Russian business is
- 1:09Speaker 1: like a candle that is burning out. So it seems
- 1:12Speaker 1: that the denial of those allegations and the positive outlook
- 1:15Speaker 1: is reassured investors quite a bit this morning, and shares
- 1:18Speaker 1: were up on the back of that. It seems that
- 1:20Speaker 1: those investors are kind of willing to move on from
- 1:22Speaker 1: this short selling report and maybe focus on that future
- 1:25Speaker 1: growth for that company.
- 1:27Speaker 3: Yeah, a very interesting one to watch there as well.
- 1:29Speaker 3: Let's turn to Zieman's next. It seems to be said
- 1:32Speaker 3: to be weighing an exit in options in Seemen's Health
- 1:35Speaker 3: in the years.
- 1:36Speaker 1: Yeah, so it's exploring a spin off of the majority stick,
- 1:39Speaker 1: the seventy one percent stick it has got in Semen's
- 1:42Speaker 1: Health in ISS, which is this medical device medical equipment company.
- 1:46Speaker 1: So Bloomberg Intelligence said that a spinoff would sharp and
- 1:49Speaker 1: strategic clarity for Simmons, essentially turning it into more of
- 1:52Speaker 1: an industrial tech a company rather than the very diversified
- 1:56Speaker 1: conglomerate that it is currently. They also said that, I
- 1:59Speaker 1: would say amplify the group structure potentially also boost valuation.
- 2:04Speaker 1: The interesting thing here is that this is a spinoff
- 2:07Speaker 1: like that of a listed subsidiary, is quite an untested structure,
- 2:11Speaker 1: especially in Germany. A direct spin off it would be
- 2:14Speaker 1: quite a rare move for a German company and it
- 2:16Speaker 1: could potentially lead to a big tax hit for investors,
- 2:20Speaker 1: so seamers will need to figure out maybe a way
- 2:22Speaker 1: to lessen that impact. Another option would be to retain
- 2:26Speaker 1: the minority at stake and then that it could sell
- 2:29Speaker 1: later on to fund other deals. So there's a lot
- 2:32Speaker 1: of different options and it's kind of unclear yet what
- 2:35Speaker 1: options it will choose. In any case, none of this
- 2:37Speaker 1: would happen until next year at the earliest, so definitely
- 2:40Speaker 1: something to keep an eye on. But in the meantime,
- 2:42Speaker 1: the shares on but in both of these companies were
- 2:44Speaker 1: up as slightly this morning on the back of that.
- 2:48Speaker 3: Okay, so let's turn it over a Nordisk next. We
- 2:50Speaker 3: did have some headlines at the open of trading in
- 2:52Speaker 3: Europe today shares rising by as much as four point
- 2:55Speaker 3: eight percent. Paired some of those gain sts what's behind
- 2:58Speaker 3: the move?
- 3:00Speaker 1: So it got upgraded to a by rating to HSBC,
- 3:03Speaker 1: so was at a hold rating now it's a buy
- 3:05Speaker 1: and Lisz said that Nova might be able to kind
- 3:08Speaker 1: of gradually turn a corner, especially if it focuses on
- 3:11Speaker 1: two of its important channels, which are the reimbust medical
- 3:15Speaker 1: channel and then the Director consumer channel as well. HSBC
- 3:19Speaker 1: analysts did say that the next generation portfolio at Nova
- 3:22Speaker 1: is suboptimal compared to Eli Lilly's portfoliobviously the most direct
- 3:26Speaker 1: rival for Nova Nordisk, though it did note that some trials,
- 3:30Speaker 1: including the Evoke trial for Alzheimer's, could be a potential catalyst.
- 3:34Speaker 1: So overall, it seems that things are moving in the
- 3:36Speaker 1: right direction for Nova Nordisk. Just yesterday was also up
- 3:39Speaker 1: on the back of Pfizer striking this deal with the
- 3:42Speaker 1: Trump administration to lower drug prices in exchange for a
- 3:45Speaker 1: TIERF reprief, so, you know, analyst said that could open
- 3:48Speaker 1: the door to other farmer companies striking similar deals, and
- 3:51Speaker 1: so it was also up on the back of that.
- 3:53Speaker 1: So it seems that things are pointing in the right direction,
- 3:56Speaker 1: that Nova is turning a corner after a quite a
- 3:59Speaker 1: lot of weakness throughout the.
- 4:01Speaker 2: The Stockmover's report from Bloomberg Radio. Check back with us
- 4:06Speaker 2: throughout the day for the latest roundup of companies making
- 4:09Speaker 2: news on Wall Street, and for the latest market moving headlines,
- 4:12Speaker 2: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg
- 4:16Speaker 2: dot com, and on Applecarplay and Android Auto with the
- 4:20Speaker 2: Bloomberg Business App.